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A routine brain MRI performed 5 months later showed a decreased level of leptomeningeal impairment ( Fig. 2A) and no subcortical oedema.
In view of the patient's medical history, complementary test results, and his clinical and radiological improvement after steroid and immunosuppressant treatment, he was diagnosed with autoimmune focal leptomeningeal encephalitis due to rheumatoid arthritis.
As mentioned above, the most frequent neurological manifestations of rheumatoid arthritis, including sensory nerve entrapment, occur in the peripheral nervous system. Effects of rheumatoid arthritis on the central nervous system may include meningeal nodules, pachymeningitis, and cerebral vasculitis.
Meningeal nodules are usually asymptomatic and typically do not invade brain parenchyma.
Rheumatoid pachymeningitis is a rare complication that may appear in late stages of the disease. It is caused by the diffuse infiltration of inflammatory cells and may present with epileptic seizures or cranial nerve compression. 2 Central nervous system vasculitis is a rare extra-articular manifestation which usually appears in advanced stages of the disease. In some cases, however, it presents as the first symptom. In cerebral vasculitis, tissue damage may arise as a result of occlusion of the inflamed blood vessels or due to a direct autoimmune mechanism. 1, 3 Few cases of rheumatoid meningoencephalitis due to vasculitis have been described, but all of them report an underlying autoimmune pathogenic mechanism. Such cases are generally treated with high doses of intravenous corticosteroids, and the treatment is usually effective. [4] [5] [6] Due to the aggressive manifestations of rheumatoid meningoencephalitis, patients with a suspected diagnosis should begin treatment with high doses of intravenous steroids so as to reduce subsequent sequelae.
